Kenya vs Libya: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and
Kenya
17.8%
in 2021
Libya
18.2%
in 2021
Kenya rank
76th
Libya rank
74th
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time
- Kenya
- Libya
How they compare
Libya currently reports 18.2% against 17.8% in Kenya, a difference of 0.4%.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Libya ahead.
Kenya ranks 76th and Libya ranks 74th of 185 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kenya | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.6% | 19.5% | 2.9% | Libya |
| 2010s | 19.0% | 19.1% | 0.1% | Libya |
| 2020s | 17.6% | 18.4% | 0.8% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Kenya or Libya?
- Libya, at 18.2% against 17.8% in Kenya as of 2021.
- What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Kenya and Libya?
- 0.4%, with Libya ahead.
- How many years of comparable data are there for Kenya and Libya?
- 22 years are reported by both, from 2000 to 2021.
- How do Kenya and Libya rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Kenya ranks 76th and Libya ranks 74th of 185 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).